TR-332: 2-Mercaptobenzothiazole (149-30-4)
Study Results
Chronic Bioassay Level of Evidence
Rats | |
---|---|
View
|
|
View
|
Mice | |
---|---|
View
|
|
View
|
Genetic Toxicology
Mammalian Cell Mutagenicity |
---|
View
|
Mammalian Cell Cytogenetics | |
---|---|
CA | SCE |
|
|
Bacterial Mutagenicity |
---|
View
|
Publications
TR-332
Toxicology and Carcinogenesis Studies of 2-Mercaptobenzothiazole (CASRN 149-30-4) in F344/N Rats and B6C3F1 Mice (Gavage Studies)
Study Data
Toxicity and Carcinogenicity Studies
Evaluation of the Chronic Toxicity and Carcinogenicity of 2-Mercaptobenzothiazole (149-30-4) in Male F344 Rats Exposed via Gavage
Evaluation of the Chronic Toxicity and Carcinogenicity of 2-Mercaptobenzothiazole (149-30-4) in Female F344 Rats Exposed via Gavage
Evaluation of the Chronic Toxicity and Carcinogenicity of 2-Mercaptobenzothiazole (149-30-4) in Male B6C3F1 Mice Exposed via Gavage
Evaluation of the Chronic Toxicity and Carcinogenicity of 2-Mercaptobenzothiazole (149-30-4) in Female B6C3F1 Mice Exposed via Gavage
Genetic Toxicology Studies
Genetic Toxicity Evaluation of 2-Mercaptobenzothiazole in Salmonella/E.coli Mutagenicity Test or Ames Test. Study 876400
Summary Data
- G06 - Ames Summary Data (145 KB)